SynthesisMedicine2019

Efficacy and safety of once daily versus twice daily mesalazine for mild-to-moderate ulcerative colitis: A meta-analysis of randomized controlled trials.

Xin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.